Genetic Tech (GENE) Surges 28% As Additional Breast Health Centres Begin Offering BREVAGenplus

Shares of molecular diagnostics firm Genetic Technologies Limited (GENE) are up $1.16, or 28%, at $5.38, in early trading, after the company this morning announced that a further two new breast health centers will begin to offer BREVAGenplus to their at-risk patients in a systematic fashion. Genetic Tech said that this is in addition to […] View the full post at: Genetic Tech (GENE) Surges 28% As Additional Breast Health Centres Begin Offering BREVAGenplus Related posts: General Motors Borrows $4 bln in Additional Federal Aid Health Care Polls: Urgency to Pass a Health Care Reform Bill Health Care Polls: Satisfaction with Publicly Provided Health Care
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.